BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 19091404)

  • 1. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
    Guo D; Ye J; Dai J; Li L; Chen F; Ma D; Ji C
    Leuk Res; 2009 May; 33(5):678-85. PubMed ID: 19091404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways.
    Jang MS; Miao H; Carlesso N; Shelly L; Zlobin A; Darack N; Qin JZ; Nickoloff BJ; Miele L
    J Cell Physiol; 2004 Jun; 199(3):418-33. PubMed ID: 15095289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
    Zhang X; Huang H; Xu Z; Zhan R
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
    Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
    J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
    Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
    Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines.
    Liu S; Breit S; Danckwardt S; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2009 Jul; 88(7):613-21. PubMed ID: 19057901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
    Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
    Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706.
    Lu Z; Liu H; Xue L; Xu P; Gong T; Hou G
    Int J Oncol; 2008 Mar; 32(3):643-51. PubMed ID: 18292942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.
    Wang L; Cao XX; Chen Q; Zhu TF; Zhu HG; Zheng L
    Cancer Sci; 2009 Oct; 100(10):1801-8. PubMed ID: 19572978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C; Klein EA; Assoian RK; Kazanietz MG
    Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
    Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
    Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH and PI3K-AKT pathways intertwined.
    Gutierrez A; Look AT
    Cancer Cell; 2007 Nov; 12(5):411-3. PubMed ID: 17996644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
    Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
    Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
    Suwanjunee S; Wongchana W; Palaga T
    Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
    Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
    Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway.
    Wang X; Sun H; Li C
    Leuk Res; 2007 May; 31(5):653-60. PubMed ID: 16950511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway.
    Ouafik L; Berenguer-Daize C; Berthois Y
    Cell Signal; 2009 Apr; 21(4):597-608. PubMed ID: 19166930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.